Old North State Trust’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Old North State Trust’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-75	Closed	-$6K	–	377
2019 Q3	$6K	Hold	75	–	–	﹤0.01%	341
2019 Q2	$7K	Hold	75	–	–	0.01%	321
2019 Q1	$6K	Hold	75	–	–	﹤0.01%	335
2018 Q4	$5K	Hold	75	–	–	0.01%	340
2018 Q3	$7K	Buy	+75	New	+$7.27K	0.01%	335

Other funds holding XBI

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of Nova Scotia Toronto, Ontario, Canada $66.2B AUM 46.3% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Natixis Paris, France $24.8B AUM 35.22% 1-Year Est. Return

Old North State Trust's XBI Position: Q4 2019 in Review

Old North State Trust sold out of State Street SPDR S&P Biotech ETF (XBI) in Q4 2019, closing a stake of 75 shares — an estimated $6K sold.

Old North State Trust first reported a position in XBI in Q3 2018 and held it in 5 quarters. The position peaked at $7K in Q2 2019. 474 funds tracked by Wall St. Rank hold XBI as of Q4 2019.

Old North State Trust reported no remaining State Street SPDR S&P Biotech ETF position as of Q4 2019 after selling out during the quarter.
Old North State Trust sold 75 State Street SPDR S&P Biotech ETF shares in Q4 2019, an estimated $6K.
Old North State Trust first reported a position in State Street SPDR S&P Biotech ETF in Q3 2018 and held it in 5 quarters.
Old North State Trust's State Street SPDR S&P Biotech ETF position peaked at $7K in Q2 2019.
474 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q4 2019.

Based on Old North State Trust's 13F filing for Q4 2019, filed 21 Feb 2020.